In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria
- PMID: 15194130
- DOI: 10.1016/j.ijantimicag.2003.10.008
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria
Abstract
The resistance rates of ampicillin/sulbactam 2:1 against imipenem-susceptible and -resistant Acinetobacter baumannii were 23.5 and 30%, respectively. Ceftazidime/sulbactam combination showed significant reduction of resistant rates against Enterobacter cloacae, A. baumannii, ESBL Klebsiella pneumoniae. MIC90 of cefoperazone against E. cloacae, Serratia marcescens, A. baumannii and ESBL K. pneumoniae were > 128 mg/l. Addition of sulbactam enhanced the antimicrobial activities significantly. When imipenem was combined with sulbactam, the resistant rates against imipenem-resistant A. baumanni were significantly reduced. Cefepime/sulbactam combination was active against imipenem-resistant A. baumanni. The resistance rates of aztreonam/sulbactam combination against E. cloacae, imipenem-sensitive and resistant A. baumannii, ESBL K. pneumoniae were lowered significantly. The cefotaxime/sulbactam combination showed a significant improvement of activities against E. cloacae, S. marcescens, A. baumannii and ESBL K. pneumoniae.
Copyright 2004 Elsevier B.V.
Similar articles
-
In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.New Microbiol. 2009 Jan;32(1):49-55. New Microbiol. 2009. PMID: 19382669
-
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].Mikrobiyol Bul. 2008 Oct;42(4):537-44. Mikrobiyol Bul. 2008. PMID: 19149074 Turkish.
-
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12820912 Chinese.
-
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!Curr Opin Microbiol. 2005 Oct;8(5):518-24. doi: 10.1016/j.mib.2005.08.014. Curr Opin Microbiol. 2005. PMID: 16126451 Review.
-
Sulbactam-containing beta-lactamase inhibitor combinations.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:185-8. doi: 10.1111/j.1469-0691.2007.01847.x. Clin Microbiol Infect. 2008. PMID: 18154545 Review.
Cited by
-
Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment.Eur J Clin Microbiol Infect Dis. 2024 Sep;43(9):1777-1785. doi: 10.1007/s10096-024-04892-x. Epub 2024 Jul 12. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38995342 Free PMC article.
-
Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii.Infect Drug Resist. 2021 Sep 28;14:3971-3977. doi: 10.2147/IDR.S332160. eCollection 2021. Infect Drug Resist. 2021. PMID: 34611414 Free PMC article.
-
Global challenge of multidrug-resistant Acinetobacter baumannii.Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23. Antimicrob Agents Chemother. 2007. PMID: 17646423 Free PMC article. Review. No abstract available.
-
Antibiofilm Activity of β-Lactam/β-Lactamase Inhibitor Combination against Multidrug-Resistant Salmonella Typhimurium.Pathogens. 2022 Mar 13;11(3):349. doi: 10.3390/pathogens11030349. Pathogens. 2022. PMID: 35335673 Free PMC article.
-
Ampicillin/sulbactam: current status in severe bacterial infections.Drugs. 2007;67(13):1829-49. doi: 10.2165/00003495-200767130-00003. Drugs. 2007. PMID: 17722953 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources